Premium
Increased frequencies of circulating CCR5 + memory T cells are correlated to chronic chagasic cardiomyopathy progression
Author(s) -
Roffe Ester,
Dos Santos Luara I.,
Santos Maykon O.,
Henriques Priscilla M.,
TeixeiraCarvalho Andrea,
MartinsFilho Olindo A.,
Rocha Manoel O. C.,
EloiSantos Silvana M.,
CorreaOliveira Rodrigo,
Antonelli Lis R. V.
Publication year - 2019
Publication title -
journal of leukocyte biology
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 1.819
H-Index - 191
eISSN - 1938-3673
pISSN - 0741-5400
DOI - 10.1002/jlb.ma1118-472r
Subject(s) - biology , cxcr3 , immunology , cd8 , chagas disease , immune system , cardiomyopathy , pathogenesis , inflammation , effector , chemokine receptor , heart failure , asymptomatic , chemokine , medicine
The infection with the protozoan parasite Trypanosoma cruzi causes Chagas disease, a neglected tropical disease in Latin America and an imported emerging disease worldwide. Chronic Chagasic cardiomyopathy (CCC), a progressive inflammatory and fibrosing disease, is the most prominent clinical form of Chagas disease, culminating in heart failure and high rates of sudden death. CCC pathogenesis is influenced by both host and parasite factors and is proposed to be mostly immune‐driven. Chemokines are crucial players in orchestrating immune cell recruitment to infected tissues and inflammation. Herein, we investigated inflammatory chemokine receptor expression on circulating T cells in patients stratified by CCC severity. Compared to asymptomatic individuals, we found increased percentages of effector CD4 + T cells and central memory CD4 + and CD8 + T cells expressing CCR5 in patients with structural cardiopathy, but normal global ventricular function and no symptoms of chronic heart failure. Even naïve T cells expressed CCR5 in these patients. In contrast, reduced frequencies of CD4 + and CD8 + effector T cells expressing CXCR3 were observed in patients presenting with severe heart disease. Patients with increased left ventricular diameter, heart enlargement, and insufficiency had higher frequencies of CCR5 + effector and effector memory CD8 + T cells. Moreover, the percentage of effector CCR5 + CD8 + T cells was increased in patients with a reduced ejection fraction. Our results show that high expression CCR5 and low expression of CXCR3 on circulating T cells are associated with worse prognosis, possibly reflecting immune‐mediated cardiac remodeling of CCC.